Our Sponsors
13th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine
Website https://go.evvnt.com/2523190-0?pid=4800 |
Edit Freely
Category Conferences ; Science ; Health ; Medicine ; CME (Continuing Medical Education)
Deadline: November 14, 2024 | Date: November 15, 2024-November 16, 2024
Venue/Country: Sofitel Los Angeles at Beverly Hills, U.S.A
Updated: 2024-07-12 15:01:16 (GMT+9)
Call For Papers - CFP
The conference will cover drug and treatment updates with a focus on precision medicine, gynecological malignancies, hematologic malignancies, prostate, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.URLs:Twitter: https://go.evvnt.com/2523190-2?pid=4800
LinkedIn: https://go.evvnt.com/2523190-3?pid=4800Date and Time: Friday, 15 November 2024 at 14:00 to Saturday, 16 November 2024 at 16:30Venue details: Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, California, 90048, United StatesPrices:Physicians: USD 125.00,All Other Healthcare Providers: USD 100.00,Residents/Fellows/Medical Students: USD 0.00,CSHS Advanced Practice Providers/Researchers/Administration: USD 0.00,Industry: USD 225.00Speakers: John Chute, MD, Robert A. Figlin, MD, Karen Reckamp, MDKeywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.